BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SHR-4298 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of SHR-4298\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07229612-11114@assetmemo.bio
DTSTAMP:20261121T004554Z
DTSTART;VALUE=DATE:20281130
DTEND;VALUE=DATE:20281201
SUMMARY:SHR-4298: Phase 1/2 readout est. (NCT07229612)
DESCRIPTION:SHR-4298\, phase 1/2.\nStudy: A Phase I/II Clinical Study of SH
 R-4298 Injection in Patients With Malignant Solid Tumors\nEstimated primar
 y completion: November 2028. This is a ClinicalTrials.gov estimate\, not a
  confirmed readout date\, and it can move.\nDrug page: https://assetmemo.b
 io/drug/shr-4298#upcoming-events\nRegistry record: https://clinicaltrials.
 gov/study/NCT07229612
URL:https://assetmemo.bio/drug/shr-4298#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
